Evidence map›Paper›PMID 33912644›Full record

ArticleGynecologic oncology reports2021

Menstural function preservation treatment of a primary vaginal clear cell carcinoma with ovarian transposition and vaginal brachytherapy.

Dimitrios-Efthymios Vlachos, Athanasios Protopapas, Georgios Vlachos, Kyrillos Sarris, Maria Sotiropoulou, Maria Terzi, Dimitris Loutradis

Open access · goldAbstract readCase Reports
In one paragraph

Article in Gynecologic oncology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Dimitrios-Efthymios Vlachos1st Department of Obstetrics and Gynecology, University of Athens, Greece.
Athanasios Protopapas1st Department of Obstetrics and Gynecology, University of Athens, Greece.
Georgios Vlachos1st Department of Obstetrics and Gynecology, University of Athens, Greece.
Kyrillos SarrisDepartment of Radiotherapy, General Hospital "Alexandra", Athens, Greece.
Maria SotiropoulouDepartment of Pathology, General Hospital "Alexandra", Athens, Greece.
Maria TerziDepartment of Pathology, 'Hygeia' Diagnostic and Therapeutic Centre of Athens - Hygeia, Greece.
Dimitris Loutradis1st Department of Obstetrics and Gynecology, University of Athens, Greece.
National and Kapodistrian University of Athens · GRAlexandra Hospital · GRHygeia Hospital · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early stage vaginal carcinomas are typically treated with radical surgical procedures or radiation therapy. Both modalities impair the reproductive ability of the patients. We hereby report a case of menstrual function preservation in a 24-year-old patient with an early-stage primary vaginal clear cell carcinoma. We treated the patient with intravaginal brachytherapy after appropriate laparoscopic surgical staging and separate transposition of the ovaries and tubes. The patient is now 6 years without any evidence of disease. She reports minor. complaints during sexual intercourse, while her menstruation and hormonic profile are normal.

Indexed as

BrachytherapyClear cell carcinomaPreservation of menstrual functionVaginal cancer

Identifiers

PMID33912644
PMCPMC8063755
OpenAlexW3155228763

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.